Security key
07725L102
BeOne Medicines Ltd. - Ordinary Shares, par value $0.0001 per share (ONC)
CUSIP: 07725L102
Q2 2025 13F Holders as of 30 Jun 2025
- Security type / class
- Equity / Ordinary Shares, par value $0.0001 per share
- Total 13F shares
- 34,445,503
- Total 13F value
- $8,338,029,358
- Share change
- -8,062,587
- Put/Call ratio
- 94%
- SEC-reported price per share
- $242.07
- Number of holders
- 240
- Value change
- -$2,097,913,474
- Number of buys
- 118
- Number of sells
- 128
- Shares outstanding
- 1,448,910,175
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2025
Institutions
240
Top holders
10
ONC full security history
Ownership snapshot
Full 13F holder table
BeOne Medicines Ltd. SEC filings
BeOne Medicines Ltd. company facts
BeOne Medicines Ltd. 13D/G history
Broader feeds
Ownership snapshot
Top reported holders of ONC - BeOne Medicines Ltd. - Ordinary Shares, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
HHLR ADVISORS, LTD.
Disclosed value leader
HHLR ADVISORS, LTD.
Comparable rows
15/15
Latest evidence
31 Mar 2025
3/4/5
13D/G
13F
Lead comparable stake: 4.9%
13D/G row: HHLR ADVISORS, LTD.
Showing 1-6 of 15 holder rows.
Quick read
HHLR ADVISORS, LTD. leads the comparable SEC ownership view at 4.9%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens HHLR ADVISORS, LTD.'s linked filing trail.
Comparable ownership
Top 5
HHLR ADVISORS, LTD.
4.9%
BAKER BROS. ADVISORS LP
0.61%
Capital International Investors
0.35%
PRIMECAP MANAGEMENT CO/CA/
0.35%
BAILLIE GIFFORD & CO
0.25%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| HHLR ADVISORS, LTD. |
3/4/5
13D/G
13F
10%+ Owner · Company
|
4.9%
from 13D/G
|
$25,009,148,200
125,045,741 shares
|
— | 02 Dec 2024 |
| BAKER BROS. ADVISORS LP |
13F
Company
|
0.61%
|
$2,394,838,255
8,799,053 shares
|
— | 31 Mar 2025 |
| Capital International Investors |
13F
Company
|
0.35%
|
$1,384,108,227
5,090,970 shares
|
— | 31 Mar 2025 |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
Company
|
0.35%
|
$1,375,956,527
5,055,504 shares
|
— | 31 Mar 2025 |
| BAILLIE GIFFORD & CO |
13F
Company
|
0.25%
|
$988,170,340
3,630,710 shares
|
— | 31 Mar 2025 |
| FMR LLC |
13F
Company
|
0.24%
|
$939,959,904
3,453,576 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
240
Shares
34,445,503
Rows available
240
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
260
Q2 2025 holders
240
Holder diff
-20
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q2 2025 value | Value change | Value Chg % |
|---|